Human equilibrative nucleoside transporter 1 gene expression is associated with gemcitabine efficacy in advanced leiomyosarcoma and angiosarcoma

BACKGROUND: The expression of human equilibrative nucleoside transporter 1 (hENT1), the major gemcitabine transporter into cells, has been thoroughly investigated as a predictive marker of response to gemcitabine in pancreatic cancer and biliary tract cancers. Since gemcitabine is widely used in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Vincenzi, Bruno, Stacchiotti, Silvia, Collini, Paola, Pantano, Francesco, Rabitti, Carla, Perrone, Giuseppe, Iuliani, Michele, Baldi, Alfonso, Badalamenti, Giuseppe, Sanfilippo, Roberta, Santini, Daniele, Muda, Andrea Onetti, Gronchi, Alessandro, Casali, Paolo, Dei Tos, Angelo Paolo, Tonini, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537497/
https://www.ncbi.nlm.nih.gov/pubmed/28641307
http://dx.doi.org/10.1038/bjc.2017.187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537497/
https://www.ncbi.nlm.nih.gov/pubmed/28641307
http://dx.doi.org/10.1038/bjc.2017.187

Ejemplares similares